Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Asfotase alfa 18mg/0.45ml solution for injection vials
0908010AMAAAAAA
|
Asfotase alfa | Asfotase alfa | Nutrition and Blood | No data available |
|
Asfotase alfa 28mg/0.7ml solution for injection vials
0908010AMAAABAB
|
Asfotase alfa | Asfotase alfa | Nutrition and Blood | No data available |
|
Asfotase alfa 40mg/1ml solution for injection vials
0908010AMAAACAC
|
Asfotase alfa | Asfotase alfa | Nutrition and Blood | No data available |
|
Asfotase alfa 80mg/0.8ml solution for injection vials
0908010AMAAADAD
|
Asfotase alfa | Asfotase alfa | Nutrition and Blood | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.